With cutting-edge research in the fields of ENERGY, HEALTH and MATTER, around 1,500 employees from more than 70 nations at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) are committed to mastering the great challenges facing society today.
At the Institute of Radiopharmaceutical Cancer Research scientists (f/m/d) from the fields of physics, chemistry, biology, pharmacy, immunology, medicine and IT develop innovative radiopharmaceuticals and novel tools for functional characterization, improved imaging and personalized treatment of tumors.
The Department of Positron Emission Tomography is looking for a
Positron emission tomography (PET) is a cornerstone of today’s cancer diagnosis, treatment planning, and response assessment. By administering specific radiotracers, PET enables the visualization and quantification of distinct physiological processes in the body. However, clinical PET imaging has so far been largely limited to imaging the distribution of a single radiotracer per scan. In collaboration with the Forschungszentrum Jülich, the PET department at HZDR has launched a joint research project to evaluate the potential of dual-tracer PET imaging. This innovative approach enables separation of two simultaneously acquired radiotracers, providing two distinct images from a single PET acquisition. Within this project, we will jointly develop, adapt and implement advanced image reconstruction algorithms in our in-house reconstruction software to evaluate the feasibility of dual-tracer imaging on clinical PET scanners – with the ultimate goal of translating this novel method towards clinical application.
Recruitment is subject to final approval by the project sponsor.
We look forward to receiving your application documents (including cover letter, CV, diplomas/transcripts, etc.), which you can submit via our online-application-system: https://www.hzdr.de/db/Cms?pNid=490&pOid=75874&pContLang=en
ID: 199414